The University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery & Innovation to develop impactful cell therapies for cancer and other conditions. Led by Dr. Katy Rezvani, the institute aims to advance immunology and cell engineering research to create new treatments quickly. MD Anderson researchers already have made significant progress in CAR T cell therapy for hematologic cancers and are working on new cell therapies for solid tumors, autoimmune diseases, and infections. The institute will collaborate with external researchers and companies to speed up development. Philanthropic support of over $80 million has laid a strong foundation for this groundbreaking research.
Source link
MD Anderson launches new institute for advancing cell therapy
